$2.65
+
$0.12 (4.53%)
End-of-day quote: 05/01/2024
NasdaqGM:CVAC
CureVac N.V. Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $571.25 | $591.94 | 0.00% | 1 | $218.05B |
| DHR | Danaher | NYSE | Outperform | $246.84 | $260.33 | 0.00% | 4 | $182.83B |
| PFE | Pfizer | NYSE | Outperform | $27.70 | $32.87 | 0.00% | 6 | $156.85B |
| SAN | Sanofi | ENXTPA | Outperform | 91.90€ | 102.80€ | 0.00% | 9 | 114.75€B |
| GSK | GSK | LSE | Outperform | £17.29 | £17.30 | 0.00% | 12 | £70.49B |
| MRNA | Moderna | NasdaqGS | Outperform | $125.59 | $135.42 | 0.00% | 1 | $48.09B |
| BNTX | BioNTech | NasdaqGS | Outperform | $92.24 | $123.75 | 0.00% | 3 | $22.23B |
| 1548 | Genscript Biotech | SEHK | Buy | HK$12.34 | HK$3.96 | 0.00% | 0 | HK$24.72B |
| TWST | Twist Bioscience | NasdaqGS | Outperform | $32.01 | $34.00 | 0.00% | 2 | $1.85B |
